A 52-year-old man from Mumbai with a 10-year history of cirrhosis secondary to hepatitis C presents to the emergency department with hematemesis and melena. On examination, he is hypotensive (BP 88/54 mmHg), tachycardic (HR 118/min), and has clinical signs of portal hypertension. Laboratory investigations show: Hb 7.8 g/dL, platelets 65,000/µL, PT 18 sec (INR 1.8), aPTT 38 sec, fibrinogen 140 mg/dL (normal 200–400 mg/dL), D-dimer elevated at 2.8 µg/mL (normal

Question

A 52-year-old man from Mumbai with a 10-year history of cirrhosis secondary to hepatitis C presents to the emergency department with hematemesis and melena. On examination, he is hypotensive (BP 88/54 mmHg), tachycardic (HR 118/min), and has clinical signs of portal hypertension. Laboratory investigations show: Hb 7.8 g/dL, platelets 65,000/µL, PT 18 sec (INR 1.8), aPTT 38 sec, fibrinogen 140 mg/dL (normal 200–400 mg/dL), D-dimer elevated at 2.8 µg/mL (normal <0.5 µg/mL). Endoscopy confirms bleeding esophageal varices. After variceal ligation and blood transfusion, the patient is started on fresh frozen plasma (FFP) and vitamin K. Despite these measures, the PT remains prolonged at 17 sec 6 hours later. What is the most likely explanation for the persistent coagulopathy?

Accepted Answer

B. Hepatic synthetic dysfunction with impaired production of clotting factors. ## Clinical Context & Pathophysiology

This patient has **cirrhosis-induced coagulopathy**, a complex disorder combining:
1. **Hepatic synthetic dysfunction** — impaired production of clotting factors (II, V, VII, IX, X, XI, XII, fibrinogen)
2. **Portal hypertension** — splenomegaly causing thrombocytopenia
3. **Impaired clearance** — reduced inactivation of fibrinolytic mediators (plasminogen activators)

## Why This Is NOT Acute DIC

**Key Point:** Although this patient has some features suggestive of DIC (low fibrinogen, elevated D-dimer, prolonged PT/aPTT), the **persistent coagulopathy despite FFP transfusion** is the critical clue that points to **hepatic synthetic dysfunction**, not consumptive coagulopathy.

## Differential: Cirrhosis vs. DIC

| Feature | Cirrhosis | DIC |
|---------|-----------|-----|
| **Fibrinogen** | Low (chronic) | Very low (acute consumption) |
| **Platelets** | Low (splenomegaly) | Very low (consumption) |
| **PT/aPTT** | Prolonged (factor deficiency) | Prolonged (consumption) |
| **D-dimer** | Mildly ↑ (impaired clearance) | Markedly ↑ (active thrombin generation) |
| **Response to FFP** | **Poor/transient** | **Good initial response** |
| **Vitamin K response** | **Poor** (liver cannot use it) | **Good** (if deficiency component) |
| **Antithrombin III** | Normal/high | Low (consumed) |
| **Prothrombin time trend** | Chronic, stable or worsening | Acute, rapidly worsening |

## Why FFP Failed to Correct PT

```mermaid
flowchart TD
  A[Cirrhotic patient with variceal bleed]:::outcome --> B{Cause of coagulopathy?}:::decision
  B -->|Hepatic synthetic dysfunction| C[Impaired production of factors II, V, VII, IX, X]:::outcome
  B -->|Consumption DIC| D[Active consumption of factors]:::outcome
  C --> E[FFP transfusion provides factors]:::action
  D --> E
  E --> F{Does PT improve?}:::decision
  F -->|Yes, sustained| G[DIC likely; factors being consumed but transfused]:::outcome
  F -->|No, or transient| H[Hepatic dysfunction likely; liver cannot produce new factors]:::outcome
  H --> I[Vitamin K ineffective because liver cannot activate factors]:::action
  I --> J[Only time + liver recovery improves coagulopathy]:::action
```

## High-Yield Pathophysiology

**High-Yield:** In cirrhosis, FFP provides a **temporary boost** of clotting factors, but because the **liver cannot synthesize new factors**, the PT remains prolonged. Vitamin K is also ineffective because:
- Vitamin K-dependent factors (II, VII, IX, X) require **hepatic carboxylation** to become active.
- A cirrhotic liver has **impaired synthetic capacity**, so even with vitamin K supplementation, factor production remains inadequate.

## Why Other Options Are Wrong

**Ongoing consumption (Option A):** While some consumption may occur during active bleeding, the **failure of FFP to sustain PT correction** is not typical of DIC. In DIC, FFP transfusion usually produces at least a transient improvement because factors are being actively consumed and replaced. Here, the PT remains persistently prolonged despite FFP, indicating the problem is **production failure**, not consumption.

**Vitamin K deficiency alone (Option C):** Cirrhotic patients often have vitamin K deficiency (malabsorption, antibiotic use), but vitamin K alone cannot correct the coagulopathy because the liver cannot activate the vitamin K-dependent factors. FFP + vitamin K should improve PT in pure vitamin K deficiency; failure to do so indicates hepatic dysfunction.

**Platelet dysfunction (Option D):** While cirrhotic patients may have qualitative platelet dysfunction, the prolonged PT is a **coagulation cascade abnormality**, not a platelet function problem. Platelet dysfunction would cause prolonged bleeding time (now abandoned) or platelet aggregation defects, not prolonged PT.

## Clinical Pearl

**"Cirrhosis = production failure; DIC = consumption failure."** FFP works in DIC (replaces consumed factors) but fails in cirrhosis (liver cannot make new factors). Vitamin K works in vitamin K deficiency but fails in cirrhosis (liver cannot use it).

## Management Implications

1. **FFP** — temporary measure only; repeated transfusions risk fluid overload.
2. **Vitamin K** — ineffective in cirrhosis; may help if concurrent deficiency.
3. **Prothrombin complex concentrate (PCC)** — more concentrated, preferred over FFP in cirrhosis.
4. **Platelet transfusion** — if platelet count <50,000/µL during active bleeding.
5. **Definitive treatment** — liver transplantation; medical management is supportive.

[cite:Harrison 21e Ch 297]

![Coagulation Disorders diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/2676.webp)

Answer

A. Vitamin K deficiency alone

Answer

C. Ongoing consumption of clotting factors due to continued bleeding and fibrinolysis

Answer

D. Platelet dysfunction secondary to uremia

Explanation

Clinical Context & Pathophysiology

Why This Is NOT Acute DIC

Differential: Cirrhosis vs. DIC

Why FFP Failed to Correct PT

High-Yield Pathophysiology

Why Other Options Are Wrong

Clinical Pearl

Management Implications

Practice similar questions

Join our NEET PG community

Feature	Cirrhosis	DIC
Fibrinogen	Low (chronic)	Very low (acute consumption)
Platelets	Low (splenomegaly)	Very low (consumption)
PT/aPTT	Prolonged (factor deficiency)	Prolonged (consumption)
D-dimer	Mildly ↑ (impaired clearance)	Markedly ↑ (active thrombin generation)
Response to FFP	Poor/transient	Good initial response
Vitamin K response	Poor (liver cannot use it)	Good (if deficiency component)
Antithrombin III	Normal/high	Low (consumed)
Prothrombin time trend	Chronic, stable or worsening	Acute, rapidly worsening